All News

Scott Sullivan, MD, highlights that a third of Virginia is a maternity desert, creating even more severe gaps for patients requiring maternal-fetal medicine.

Routine ultrasound screening at 35 to 37 weeks demonstrates limited accuracy for large-for-gestational age according to new data published in AJOG.

"Given the upper limits of the CI, a relatively higher risk of more than 12% for autism is unlikely to be associated with acetaminophen exposure," the study authors noted.

"These recommendations underscore the important and nuanced role of BMI in women’s health," write the authors.

MMRC data highlight that preventing pregnancy-related infection deaths requires multilevel interventions spanning patient education, provider training, and system readiness, with the AIM obstetric sepsis bundle representing a practical framework while broader outcomes evidence remains limited.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Investigators behind a national EHR study of perinatal GLP-1 RA prescribing acknowledge that the data cannot distinguish inadvertent early-pregnancy exposure from planned preconception discontinuation, and call for deeper, outcomes-focused research to build on the prescribing trends they identified.

While mortality declined by 9.8% in non-ban states, states with abortion bans saw much smaller declines and descriptive increases among non-Hispanic Black and Asian individuals.

New data from JAMA Cardiology indicates that 17.8% of women developed hypertension within 7 years of their first pregnancy, influenced by genetics, BMI, and HDP history.

Natalia C. Llarena, MD, FACOG, highlights the importance of clinical diagnosis and earlier symptom recognition for endometriosis to help patients find relief faster.

The FDA cleared the Onclarity HPV Self-Collection Kit, allowing patients to collect samples at home for processing via the FDA-cleared BD Onclarity HPV Assay and BD COR System.

LiSWT may offer a noninvasive option for postpartum pelvic pain, with potential benefits across both chronic and earlier-stage scar-related dysfunction.

A randomized controlled trial among sexually active premenopausal women found that anterior wall PRP injections vs control led to greater improvement in sexual function.

The Ringza slow-release vaginal ring has launched in Canada and is designed to be re-used for up to 1 year.

PinkDx announced an IJGC publication of data that demonstrated signals associated with endometrial cancer can be detected from a vaginal swab.

In this discussion, Ramu Perni, MD, MBA, details the benefits of using a non-invasive prenatal red blood cell fetal antigen test for pregnancies affected by or at risk for HDFN.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Researchers developed a porous membrane organ-on-a-chip that replicates the human cervix to study how the microbiome and immune system interact with chlamydia and gonorrhea.

The successful implementation of a privacy-centered, iPad-based substance use screening tool on labor and delivery required multiyear planning, cross-disciplinary staff education, and close collaboration with institutional informatics teams, with formal patient experience assessment planned as a next step.

According to Karen Yeo, PhD, the use of 100 to 200 PBPK models is moving drug administration toward a more personalized, informed decision-making process for pregnant women.

In this video from the 2026 American College of Cardiology Annual Scientific Session & Expo, Amy Sarma, MD, details associations of cardiovascular disease and menopause.

Azad and colleagues at Columbia University found that drug overdose, homicide, and suicide are the leading causes of death among pregnant and postpartum women.

Adnan I. Qureshi, MD, advocates for the integration of neurologists into obstetric teams to manage the increased stroke risk among pregnant persons with a previous stroke.

Take a quick look at our top 10 headlines from the first quarter of 2026.

Take a look back at some of the top FDA-related news items—from de Novo clearances to advancing trials—that Contemporary OB/GYN covered in the first quarter of 2026.

Simon highlights the "seamless handoff" between FQHCs and OB hospitalists as a vital mechanism for maintaining delivery access in rural and underserved communities.

A before-and-after cohort study of more than 18,000 patients found that universal aspirin 162 mg dispensation at the first prenatal visit was associated with a 29% reduction in preeclampsia with severe features, with benefit observed across patients with and without chronic hypertension and no increase in hemorrhagic complications.